Dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (pts) with metastatic breast carcinoma (MBC): A phase I/II study. Background: In the absence of curative treatment for the ...
The lectures on this page should be watched before the live sessions on Monday, June 6, 2022 (Tuesday, June 7 in some time zones). Total viewing time for this lecture series is 2 hours 03 minutes.
Using stock data that covers the period from April 6, 2001 to June 17, 2009, including data for the recent crisis period, we perform value-at-risk (VaR) risk model validation by backtesting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback